Amal Melhem-Bertrandt

Amal Melhem-Bertrandt currently serves as the Therapeutic Area Head for Oncology Clinical Development at Jazz Pharmaceuticals, a position held since November 2024. Prior experience includes the role of Vice President of Clinical Development at Takeda Oncology from September 2021 to February 2025, and Executive Medical Director at AbbVie between September 2019 and September 2021. Amal held the position of Senior Medical Director at Astellas Pharma from December 2013 to September 2019, following an academic role as Assistant Professor in Breast Medical Oncology at MD Anderson Cancer Center from August 2009 to December 2013. Amal Melhem-Bertrandt's educational background includes an Internal Medicine Residency Program at The University of Texas Health Science Center at Houston and a fellowship in oncology from the University of Chicago.